BioCurex Announces Commercialization Of OncoPet RECAFTM, The First Blood Test For Cancer Detection In Companion Animals
12 Feb 2010 BioCurex Inc. (OTCBB:BOCX), a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, announced that it has launched the commercialization of its OncoPet RECAF test for cancer detection in dogs. Continue Reading »
Posted in Pain management
Medication can be used to treat chronic or acute pain in dogs.
Chronic pain is associated with conditions such as arthritis or dysplasia:
Acute pain may be caused by surgery or injury. Some medications are used for both types of pain. Continue for pain medication charts and comparisons. Continue Reading »
Posted in Genetics and Breeding, Inherited Disorders
From Victoria, Australia
Department of Primary Industries 2009
Breeding programs must consider the effects and ethics of high risk mating combinations that may, based on the principles of genetic inheritance, in theory produce animals with heritable disease. Where such heritable disease has potential to cause severe welfare issues for affected progeny such breeding programs must be justifiable. Affected progeny must be assessed and humanely destroyed if they suffer. Such animals must not be used for breeding. Continue Reading »
Posted in Vaccines
24 Jun 2009
Canine influenza was first identified in the United States in 2004. Since then, CIV has continued to spread and has now been detected in dogs in 30 states and the District of Columbia, according to Dr. Crawford and Edward J. Dubovi, Ph.D., Professor of Virology, Cornell University College of Veterinary Medicine, two of the nation’s leading experts on Canine H3N8 who have been tracking the disease since 2004. Continue Reading »
http://www.medicalnewstoday.com/articles/152760.php
Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved the first canine cancer therapy in the U.S. - PALLADIATM (toceranib phosphate) - which was developed by Pfizer to treat mast cell tumors in dogs. Pfizer made the announcement to veterinarians attending the 2009 American College of Veterinary Internal Medicine (ACVIM) Forum and Canadian Veterinary Medical Association Convention. Continue Reading »
May 11, 2009
The Food and Drug Administration announced today the approval of Vetoryl (trilostane) Capsules, a new drug for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism, commonly known as Cushing’s disease. Vetoryl, a new molecular entity, is the first drug approved to treat both pituitary- and adrenal-dependent Cushing’s disease in dogs. Continue Reading »
Posted in Health
“Our data shows a clear statistical link between gum disease and heart disease in dogs,” said Larry Glickman, a professor of epidemiology,…For his research, Glickman examined records of 59,296 dogs with gum disease and matched them to those of a similar number of dogs without gum problems. He followed the dogs over time to see which ones developed heart diseases and the type of heart disease that developed. He then did statistical tests to see if the incidence of heart disease would increase as the severity of the gum disease increased.”
WebCanine.com
Information for People who care for Dogs
There are 160 Articles
to date.
Getting a new dog? Rescue or puppy?
Trying to think of all the considerations before you jump into that choice? Have questions about feeding, training, general dog health problem? Read over the general health page and training resource links then if you still have questions Email us, we will work on some solutions for you. Want to know something about a new technique or research area?
Let us know, we will help if we can.
No charge, no ads, no selling, ever.
Contact Us
